You just read:

Salix Enters Into License Agreement With The University Of California To Develop And Commercialize Novel Compound For The Treatment Of Non-alcoholic Fatty Liver Disease And Non-alcoholic Steatohepatitis

News provided by

Bausch Health Companies Inc.

Apr 01, 2019, 07:00 ET